Financials
Reported figures only · latest: Q4 2025
USD · IFRS
Source: SEC XBRL filings
· latest filing
The long view
Fiscal years as reported · SEC XBRL filings, IFRS
Revenue and net income8 fiscal yearsShow the numbers
| Year | Revenue | Net income |
|---|
| FY25 | $107.9M | −$33.5M |
|---|
| FY24 | $90M | −$38.1M |
|---|
| FY23 | $70.2M | −$43.1M |
|---|
| FY22 | $37.1M | −$44M |
|---|
| FY21 | $22.2M | - |
|---|
| FY20 | $18.5M | - |
|---|
| FY19 | $11.8M | −$43.1M |
|---|
| FY18 | - | - |
|---|
MarginsShare of revenue- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|
| FY25 | 64.5% | −13.4% | −31.1% |
|---|
| FY24 | 61.2% | −27.5% | −42.3% |
|---|
| FY23 | 62.6% | −38.9% | −61.4% |
|---|
| FY22 | 51.9% | −102.3% | −118.9% |
|---|
| FY21 | 47.5% | −120.7% | - |
|---|
| FY20 | 43.6% | −146.9% | - |
|---|
| FY19 | 0.3% | −366.3% | −365.7% |
|---|
| FY18 | - | - | - |
|---|
Free cash flowOperating cash flow minus capital expenditureShow the numbers
| Year | Free cash flow |
|---|
| FY25 | −$3.3M |
|---|
| FY24 | −$19.7M |
|---|
| FY23 | −$24.2M |
|---|
| FY22 | −$36.9M |
|---|
| FY21 | −$23.4M |
|---|
| FY20 | −$20.8M |
|---|
| FY19 | −$22.4M |
|---|
| FY18 | - |
|---|
Net margin vs the sectorMedian of Healthcare companies filing with the SEC- MDxHealth
- Healthcare median
Show the numbers
| Year | MDxHealth | Healthcare median |
|---|
| FY25 | −31.1% | −30.6% |
|---|
| FY24 | −42.3% | −47% |
|---|
| FY23 | −61.4% | −58% |
|---|
| FY22 | −118.9% | −80.4% |
|---|
| FY21 | - | −71.9% |
|---|
| FY20 | - | −62.2% |
|---|
| FY19 | −365.7% | −46.3% |
|---|
| FY18 | - | −49.6% |
|---|